India Globalization Cap.Inc. Registered Shares DL -,01

WKN A1T87A ISIN US45408X3089

Quote/Chart

  • Bid

    0.268

    1,100 Units

  • Ask

    0.28

    1,100 Units

  • Change compared with previous day (price)

    +0.01 / +4.76 %

  • Spread (Act/ Rel)

    0.012 / 4.478 %

  • Today's high (Price)

    0.264

  • Today's low (Price)

    0.264

Facts & figures

Price data

Trade platform Börse Stuttgart (XSTU)  
Last price 0.264 G 0 Units
Price determination time 02/21/2024 / 09:47:27 AM
Daily volume (units) 0
Daily high / low 0.264 0.264
Prev. day's price 0.252 (20.02.)
Change day before +0.01 4.76 %
52 week high / low 0.432 (12/09) 0.216 (12/01)

Key Figures (in EUR)

2023 2022 2021
Earnings per share - -0.21 -0.26
Dividends per share - 0.00 0.00
Dividend Yield in % - 0.00% 0.00%
Dividend growth in % - - -
Price - Earnings ratio - - -
Price - Book ratio - 1.21 2.03
Price - Sales ratio - 19.59 119.49
Price - Cash Flow Ratio - - -

ESG Data

Please log in to see the ESG data for this stock.

Not registered yet? Create an account here.

Master Data

WKN
A1T87A
ISIN
US45408X3089
Symbol
-
Exchange segment
Open Market
Type of financial instrument
Equity
Denomination
India Globalization Capital
Index membership
-
Trading segment
-
Trading hours
08:00:00 - 22:00:00
Trading currency
Euro
Nominal currency
-
Settlement currency
Euro
Sector and industry
Chemical/Pharmaceutical/Health, Health Services
Number of shares
-
Market capitalisation
-

Performance overview

1W 1M 3M 6M 1Y 3Y 5Y YTD
Performance -6.67% 12.50% 5.88% -10.00% -26.19% -83.93% -44.86% -3.82%
High 0.27 0.29 0.29 0.43 0.43 3.63 3.63 0.29
Low 0.24 0.22 0.22 0.22 0.22 0.22 0.22 0.22

Company profile

IGC Pharma, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment is involved in the rental of heavy construction equipment, execution of construction contracts, and purchase and resale of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.